Nelson Whistance Named VP of U.S. Sales At Gynesonics

AlixPartners Forecasts: Household Products Could Cost U.S. Manufacturers and Consumers 15% More This Year Due to Resin Shortage

While companies can’t control the market forces at play, they can take action to mitigate the risk and impact of supply chain disruption.

How To Control a Radio Frequency (RF) Process

The radio frequency welding and manufacturing process uses electromagnetic energy and pressure to fuse and permanently bond vinyl, thermoplastic, and coated materials to produce a specific product - all according to customer requirements. Using this RF sealing process, a distinct, one-piece perpetual bond is formulated that is both solid and resistant to ripping or tearing. But how is this process controlled, and with what specific tools? Read on.

Nelson Whistance has been named Vice President of U.S. sales of Gynesonics. The news was announced today.

“Nelson Whistance is a proven sales leader that has spent the majority of his medical device career driving commercial business in minimally invasive gynecologic surgery. He brings a strong combination of business acumen, process-oriented leadership, has exceptional clinical expertise and a track record of developing world-class training programs for physicians and commercial teams, that will enable us to scale rapidly. Nelson will support our mission of creating an impactful and lasting improvement in the standard of care for women who suffer from symptomatic uterine fibroids,” Owens said. “As we are on the precipice of the full commercial launch of our Sonata® 2 next-generation system, Nelson adds these critical elements to the executive leadership team along with his proven success in driving disruptive technology adoption in the U.S. and Canada.”

Nelson Whistance said, “I’m thrilled to be joining Gynesonics at such a critical inflection point, as we are rapidly expanding access to this groundbreaking technology in the U.S. and globally. The Sonata procedure is going to revolutionize the care of women with symptomatic uterine fibroids, and I’m honored to have been selected to build a world-class sales organization that will live up to its promise.”

Prior to joining Gynesonics, Mr. Whistance has successfully grown businesses and led commercial teams for various healthcare companies in the United States and Canada. He has led sales teams in multiple product launches, partnered with physician leaders to drive site-of-care optimization and built top quality sales training and development programs.

Previously, Mr. Whistance was Vice President of Sales and Marketing for Prytime Medical Devices, supporting the commercial market adoption of the ER-REBOA™ Catheter portfolio. Prior to Prytime, Mr. Whistance held various positions in sales, sales field training and sales management for the surgical division of Hologic supporting the MyoSure® and NovaSure® gynecological technologies. Mr. Whistance has held various sales and leadership roles for American Medical Systems, Servier Canada Pharmaceuticals, and Sysco Edmonton.

Mr. Whistance is a graduate of the University of Alberta, with a bachelor’s degree in Secondary Education.




Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.